InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
63,208.88
(
0.01%
)
Post# of 253169
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

miljenko

Send PM Follow Ignore
Followers 4
Posts 313
Boards Moderated 0
Alias Born 11/21/2011

miljenko

Re: bladerunner1717 post# 228350

Wednesday, 01/22/2020 11:54:26 PM

Wednesday, January 22, 2020 11:54:26 PM

Post# of 253169
MGNX: Marg OS benefit (difference) was weak, and for 3L/2L HER2-BC there is already better choices (from SGEN and Roche), so most likely not than yes to be recommended by AC.

Overall, small chance for approval, IMO.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up